- Home
- IFRX vs CSTE Comparison
IFRX vs CSTE Comparison
Compare IFRX & CSTE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IFRX
- CSTE
- Stock Information
- Founded
- IFRX 2007
- CSTE 1987
- Country
- IFRX Germany
- CSTE Israel
- Employees
- IFRX N/A
- CSTE N/A
- Industry
- IFRX Biotechnology: Pharmaceutical Preparations
- CSTE Building Materials
- Sector
- IFRX Health Care
- CSTE Industrials
- Exchange
- IFRX Nasdaq
- CSTE Nasdaq
- Market Cap
- IFRX 53.5M
- CSTE 61.9M
- IPO Year
- IFRX 2017
- CSTE 2012
- Fundamental
- Price
- IFRX $0.85
- CSTE $1.76
- Analyst Decision
- IFRX Strong Buy
- CSTE Strong Buy
- Analyst Count
- IFRX 4
- CSTE 1
- Target Price
- IFRX $7.75
- CSTE $6.00
- AVG Volume (30 Days)
- IFRX 371.5K
- CSTE 198.3K
- Earning Date
- IFRX 08-07-2025
- CSTE 08-06-2025
- Dividend Yield
- IFRX N/A
- CSTE N/A
- EPS Growth
- IFRX N/A
- CSTE N/A
- EPS
- IFRX N/A
- CSTE N/A
- Revenue
- IFRX $140,242.00
- CSTE $424,487,000.00
- Revenue This Year
- IFRX N/A
- CSTE N/A
- Revenue Next Year
- IFRX $6,309.47
- CSTE $6.60
- P/E Ratio
- IFRX N/A
- CSTE N/A
- Revenue Growth
- IFRX 30.90
- CSTE N/A
- 52 Week Low
- IFRX $0.71
- CSTE $1.62
- 52 Week High
- IFRX $2.82
- CSTE $6.54
- Technical
- Relative Strength Index (RSI)
- IFRX 45.30
- CSTE 46.41
- Support Level
- IFRX $0.78
- CSTE $1.75
- Resistance Level
- IFRX $0.93
- CSTE $1.89
- Average True Range (ATR)
- IFRX 0.05
- CSTE 0.09
- MACD
- IFRX 0.03
- CSTE -0.01
- Stochastic Oscillator
- IFRX 42.32
- CSTE 25.61
About IFRX InflaRx N.V.
InflaRx NV is a clinical-stage biopharmaceutical company focused on applying proprietary anti-C5a/C5aR technology to discover and develop first-in-class, potent, and specific inhibitors of the complement activation factor known as C5a and its receptor known as C5aR. C5a is an inflammatory mediator involved in the progression of a wide variety of autoimmune and other inflammatory diseases. Its product candidate, vilobelimab, is a novel intravenously delivered first-in-class anti-C5a monoclonal antibody that selectively binds to free C5a and has demonstrated disease-modifying clinical activity and tolerability in multiple clinical settings.
About CSTE Caesarstone Ltd.
Caesarstone Ltd manufactures engineered quartz surfaces. Its products include engineered quartz and porcelain slabs, which are used as kitchen countertops in renovation and remodeling, and residential construction. It also has other applications, including vanity tops, wall panels, backsplashes, floor tiles, stairs, and other interior surfaces that are used in various residential and non-residential applications. The company sells its products under the Caesarstone brand. Caesarstone's geographical segments are the United States, Canada, Latin America, Australia, Asia, Israel, and EMEA(Europe, Middle East, Africa).